Opinion: The Patent System Fails nonprofit Inventors

Background For the 2022 year, pharmaceutical company Pfizer projects $32 billion in sales from COVID-19 vaccines alone. This estimate is derived from Pfizer’s current vaccine patent contracts. Despite worldwide shortages in booster doses, the company r ...